Journal of the American Pharmacists Association : JAPhA
-
J Am Pharm Assoc (2003) · Nov 2009
White paper on designing a risk evaluation and mitigation strategies (REMS) system to optimize the balance of patient access, medication safety, and impact on the health care system.
To convene a group of expert stakeholders to develop recommendations for standardizing systems for the implementation of risk evaluation and mitigation strategies (REMS). ⋯ Several strategies to streamline the development and implementation of a REMS system are feasible. Incorporating such strategies is necessary to manage the rapidly growing number of individual and diverse REMS programs that patients and health care providers must navigate. Furthermore, a standardized REMS system could be used to improve quality of care and support patient education and empowerment.
-
J Am Pharm Assoc (2003) · Nov 2009
Physician attitudes toward collaborative agreements with pharmacists and their expectations of community pharmacists' responsibilities in West Virginia.
To (1) investigate physicians' expectations about community pharmacist's roles and physician attitudes toward collaborative agreements with community pharmacists in West Virginia and (2) determine physicians' perceptions of pharmacists providing medication therapy management (MTM) services. ⋯ Of the physician respondents, 60% reported a favorable attitude toward collaborative practice agreements, but their attitude toward pharmacists' role in collaborative drug therapy management and pharmacists providing MTM services were not that favorable. Participating physicians may not have consistent expectations regarding pharmacists providing patient care.
-
J Am Pharm Assoc (2003) · Nov 2009
Impact on drug cost and use of Medicare part D of medication therapy management services delivered in 2007.
To describe experiences with medication therapy management (MTM) services delivered to benefciaries of Mirixa's health plan clients. ⋯ Among patients who received MTM services in 2007, drug costs decreased for those who received service from community pharmacists, decreased somewhat for patients who received service from a call center pharmacist, and were unchanged for those who received MTM via mailing. Further studies are needed to assess the effect of various types of MTM interventions on fnancial, clinical, and humanistic outcomes.